Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 318

1.

NAD+ cleavage activity by animal and plant TIR domains in cell death pathways.

Horsefield S, Burdett H, Zhang X, Manik MK, Shi Y, Chen J, Qi T, Gilley J, Lai JS, Rank MX, Casey LW, Gu W, Ericsson DJ, Foley G, Hughes RO, Bosanac T, von Itzstein M, Rathjen JP, Nanson JD, Boden M, Dry IB, Williams SJ, Staskawicz BJ, Coleman MP, Ve T, Dodds PN, Kobe B.

Science. 2019 Aug 23;365(6455):793-799. doi: 10.1126/science.aax1911.

PMID:
31439792
2.

Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence.

Lukacs M, Gilley J, Zhu Y, Orsomando G, Angeletti C, Liu J, Yang X, Park J, Hopkin RJ, Coleman MP, Zhai RG, Stottmann RW.

Exp Neurol. 2019 Oct;320:112961. doi: 10.1016/j.expneurol.2019.112961. Epub 2019 May 25.

PMID:
31136762
3.

Homozygous NMNAT2 mutation in sisters with polyneuropathy and erythromelalgia.

Huppke P, Wegener E, Gilley J, Angeletti C, Kurth I, Drenth JPH, Stadelmann C, Barrantes-Freer A, Brück W, Thiele H, Nürnberg P, Gärtner J, Orsomando G, Coleman MP.

Exp Neurol. 2019 Oct;320:112958. doi: 10.1016/j.expneurol.2019.112958. Epub 2019 May 24.

PMID:
31132363
4.
5.

The Mortality-to-Incidence Ratio Is Not a Valid Proxy for Cancer Survival.

Ellis L, Belot A, Rachet B, Coleman MP.

J Glob Oncol. 2019 May;5:1-9. doi: 10.1200/JGO.19.00038.

6.

Cancer survival trends in Kuwait, 2000-2013: A population-based study.

Alawadhi E, Al-Awadi A, Elbasmi A, Coleman MP, Allemani C.

Gulf J Oncolog. 2019 Jan;1(29):39-52.

PMID:
30956195
7.

A Novel Approach to Obtain Follow-up Data on the Vital Status of Registered Cancer Patients: The Kuwait Cancer Registry Experience.

Alawadhi E, Al-Awadi A, Elbasmi A, Coleman MP, Allemani C.

Gulf J Oncolog. 2019 Jan;1(29):31-38.

PMID:
30956194
8.

Childhood cancer burden: a review of global estimates.

Bhakta N, Force LM, Allemani C, Atun R, Bray F, Coleman MP, Steliarova-Foucher E, Frazier AL, Robison LL, Rodriguez-Galindo C, Fitzmaurice C.

Lancet Oncol. 2019 Jan;20(1):e42-e53. doi: 10.1016/S1470-2045(18)30761-7. Review.

PMID:
30614477
9.

Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study.

Benitez Majano S, Di Girolamo C, Rachet B, Maringe C, Guren MG, Glimelius B, Iversen LH, Schnell EA, Lundqvist K, Christensen J, Morris M, Coleman MP, Walters S.

Lancet Oncol. 2019 Jan;20(1):74-87. doi: 10.1016/S1470-2045(18)30646-6. Epub 2018 Dec 10.

10.

Adult leukemia survival trends in the United States by subtype: A population-based registry study of 370,994 patients diagnosed during 1995-2009.

Bailey C, Richardson LC, Allemani C, Bonaventure A, Harewood R, Moore AR, Stewart SL, Weir HK, Coleman MP; CONCORD Working Group (US members).

Cancer. 2018 Oct 1;124(19):3856-3867. doi: 10.1002/cncr.31674. Epub 2018 Oct 21.

11.

P7C3-A20 neuroprotection is independent of Wallerian degeneration in primary neuronal culture.

Hill CS, Menon DK, Coleman MP.

Neuroreport. 2018 Dec 12;29(18):1544-1549. doi: 10.1097/WNR.0000000000001146.

12.

Low levels of NMNAT2 compromise axon development and survival.

Gilley J, Mayer PR, Yu G, Coleman MP.

Hum Mol Genet. 2019 Feb 1;28(3):448-458. doi: 10.1093/hmg/ddy356.

PMID:
30304512
13.

Which indicators of early cancer diagnosis from population-based data sources are associated with short-term mortality and survival?

Muller P, Walters S, Coleman MP, Woods L.

Cancer Epidemiol. 2018 Oct;56:161-170. doi: 10.1016/j.canep.2018.07.010. Epub 2018 Jul 25.

14.

Characterization of the histologic appearance of normal gill tissue using special staining techniques.

Smith SA, Newman SJ, Coleman MP, Alex C.

J Vet Diagn Invest. 2018 Sep;30(5):688-698. doi: 10.1177/1040638718791819. Epub 2018 Jul 20.

15.

Publisher Correction: TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD.

White MA, Kim E, Duffy A, Adalbert R, Phillips BU, Peters OM, Stephenson J, Yang S, Massenzio F, Lin Z, Andrews S, Segonds-Pichon A, Metterville J, Saksida LM, Mead R, Ribchester RR, Barhomi Y, Serre T, Coleman MP, Fallon JR, Bussey TJ, Brown RH Jr, Sreedharan J.

Nat Neurosci. 2018 Aug;21(8):1138. doi: 10.1038/s41593-018-0160-y.

PMID:
29872124
16.

Interaction between a MAPT variant causing frontotemporal dementia and mutant APP affects axonal transport.

Adalbert R, Milde S, Durrant C, Ando K, Stygelbout V, Yilmaz Z, Gould S, Brion JP, Coleman MP.

Neurobiol Aging. 2018 Aug;68:68-75. doi: 10.1016/j.neurobiolaging.2018.03.033. Epub 2018 Apr 5.

17.

How Do Biological Characteristics of Primary Intracranial Tumors Affect Their Clinical Presentation in Children and Young Adults?

Chu TPC, Shah A, Walker D, Coleman MP.

J Child Neurol. 2018 Jul;33(8):503-511. doi: 10.1177/0883073818767562. Epub 2018 May 3.

18.

Characteristics of patients with missing information on stage: a population-based study of patients diagnosed with colon, lung or breast cancer in England in 2013.

Di Girolamo C, Walters S, Benitez Majano S, Rachet B, Coleman MP, Njagi EN, Morris M.

BMC Cancer. 2018 May 2;18(1):492. doi: 10.1186/s12885-018-4417-3.

19.

Reply to Colon cancer survival in the US Department of Veterans Affairs by race and stage: 2001 through 2009.

White A, Rim SH, Joseph DA, Johnson CJ, Coleman MP, Allemani C.

Cancer. 2018 Jul 1;124(13):2859-2860. doi: 10.1002/cncr.31523. Epub 2018 Apr 30. No abstract available.

20.

TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD.

White MA, Kim E, Duffy A, Adalbert R, Phillips BU, Peters OM, Stephenson J, Yang S, Massenzio F, Lin Z, Andrews S, Segonds-Pichon A, Metterville J, Saksida LM, Mead R, Ribchester RR, Barhomi Y, Serre T, Coleman MP, Fallon JR, Bussey TJ, Brown RH Jr, Sreedharan J.

Nat Neurosci. 2018 Apr;21(4):552-563. doi: 10.1038/s41593-018-0113-5. Epub 2018 Mar 19. Erratum in: Nat Neurosci. 2018 Aug;21(8):1138.

21.

Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, 1996-2013: population based study.

Exarchakou A, Rachet B, Belot A, Maringe C, Coleman MP.

BMJ. 2018 Mar 14;360:k764. doi: 10.1136/bmj.k764.

22.

Conference report: improving outcomes for gastrointestinal cancer in the UK.

Forgacs I, Ashton R, Allum W, Bowley T, Brown H, Coleman MP, Fitzgerald R, Glynn M, Hiom S, Jones R, Machesney M, Maher J, Pereira SP, Steele R, Veitch A, Wyatt S.

Frontline Gastroenterol. 2018 Jan;9(1):49-61. doi: 10.1136/flgastro-2016-100713. Epub 2016 Jun 14. Review. No abstract available.

23.

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, Ogunbiyi OJ, Azevedo E Silva G, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP; CONCORD Working Group.

Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. Epub 2018 Jan 31.

24.

Which patients are not included in the English Cancer Waiting Times monitoring dataset, 2009-2013? Implications for use of the data in research.

Di Girolamo C, Walters S, Gildea C, Benitez Majano S, Coleman MP, Rachet B, Morris M.

Br J Cancer. 2018 Mar 6;118(5):733-737. doi: 10.1038/bjc.2017.452. Epub 2018 Jan 18.

25.

Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD-2 study.

Tai EW, Ward KC, Bonaventure A, Siegel DA, Coleman MP.

Cancer. 2017 Dec 15;123 Suppl 24:5178-5189. doi: 10.1002/cncr.30899.

26.

Population-based cancer survival (2001 to 2009) in the United States: Findings from the CONCORD-2 study.

Weir HK, Stewart SL, Allemani C, White MC, Thomas CC, White A, Coleman MP; CONCORD Working Group (US Members).

Cancer. 2017 Dec 15;123 Suppl 24:4963-4968. doi: 10.1002/cncr.31028. No abstract available.

27.

Rectal cancer survival in the United States by race and stage, 2001 to 2009: Findings from the CONCORD-2 study.

Joseph DA, Johnson CJ, White A, Wu M, Coleman MP.

Cancer. 2017 Dec 15;123 Suppl 24:5037-5058. doi: 10.1002/cncr.30882.

28.

Colon cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

White A, Joseph D, Rim SH, Johnson CJ, Coleman MP, Allemani C.

Cancer. 2017 Dec 15;123 Suppl 24:5014-5036. doi: 10.1002/cncr.31076.

29.

Population-based cancer survival in the United States: Data, quality control, and statistical methods.

Allemani C, Harewood R, Johnson CJ, Carreira H, Spika D, Bonaventure A, Ward K, Weir HK, Coleman MP.

Cancer. 2017 Dec 15;123 Suppl 24:4982-4993. doi: 10.1002/cncr.31025.

30.

Public health surveillance of cancer survival in the United States and worldwide: The contribution of the CONCORD programme.

Allemani C, Coleman MP.

Cancer. 2017 Dec 15;123 Suppl 24:4977-4981. doi: 10.1002/cncr.30854.

31.

Sarm1 Deletion, but Not WldS, Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy.

Gilley J, Ribchester RR, Coleman MP.

Cell Rep. 2017 Oct 3;21(1):10-16. doi: 10.1016/j.celrep.2017.09.027.

32.

Reply to correspondence "Do big numbers assure high-quality of data?"

Allemani C, Bonaventure A, Harewood R, Di Carlo V, Coleman MP.

Lancet Haematol. 2017 Sep;4(9):e410. doi: 10.1016/S2352-3026(17)30151-5. No abstract available.

PMID:
28863802
33.

Erratum to "Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 396-404].

Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C; CONCORD Working Group.

Gynecol Oncol. 2017 Dec;147(3):725. doi: 10.1016/j.ygyno.2017.06.033. Epub 2017 Jul 5. No abstract available.

PMID:
28688523
34.

Erratum to "The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 405-413].

Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C; CONCORD Working Group; Africa.

Gynecol Oncol. 2017 Dec;147(3):726. doi: 10.1016/j.ygyno.2017.06.032. Epub 2017 Jul 5. No abstract available.

PMID:
28687170
35.

Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.

Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC, Carreira H, Spika D, Marcos-Gragera R, Peris-Bonet R, Piñeros M, Sant M, Kuehni CE, Murphy MFG, Coleman MP, Allemani C; CONCORD Working Group.

Lancet Haematol. 2017 May;4(5):e202-e217. doi: 10.1016/S2352-3026(17)30052-2. Epub 2017 Apr 11. Erratum in: Lancet Haematol. 2017 May;4(5):e201.

36.

NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo.

Di Stefano M, Loreto A, Orsomando G, Mori V, Zamporlini F, Hulse RP, Webster J, Donaldson LF, Gering M, Raffaelli N, Coleman MP, Gilley J, Conforti L.

Curr Biol. 2017 Mar 20;27(6):784-794. doi: 10.1016/j.cub.2017.01.070. Epub 2017 Mar 2.

37.

Life tables for global surveillance of cancer survival (the CONCORD programme): data sources and methods.

Spika D, Bannon F, Bonaventure A, Woods LM, Harewood R, Carreira H, Coleman MP, Allemani C.

BMC Cancer. 2017 Feb 27;17(1):159. doi: 10.1186/s12885-017-3117-8.

38.

The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2).

Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C; & the CONCORD Working Group.

Gynecol Oncol. 2017 Feb;144(2):405-413. doi: 10.1016/j.ygyno.2016.10.019. Epub 2016 Dec 6. Erratum in: Gynecol Oncol. 2017 Dec;147(3):726.

39.

Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2).

Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C; CONCORD Working Group.

Gynecol Oncol. 2017 Feb;144(2):396-404. doi: 10.1016/j.ygyno.2016.11.019. Epub 2016 Dec 2. Erratum in: Gynecol Oncol. 2017 Dec;147(3):725.

40.

A review of the peri-operative management of paediatric burns: Identifying adverse events.

Rode H, Brink C, Bester K, Coleman MP, Baisey T, Martinez R.

S Afr Med J. 2016 Nov 2;106(11):1114-1119. doi: 10.7196/SAMJ.2016.v106i11.10938.

PMID:
27842634
41.

Where are the opportunities for an earlier diagnosis of primary intracranial tumours in children and young adults?

Chu TPC, Shah A, Walker D, Coleman MP.

Eur J Paediatr Neurol. 2017 Mar;21(2):388-395. doi: 10.1016/j.ejpn.2016.10.010. Epub 2016 Oct 31.

42.

The global burden of women's cancers: a grand challenge in global health.

Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, Sarker M, Huong TT, Allemani C, Dvaladze A, Gralow J, Yeates K, Taylor C, Oomman N, Krishnan S, Sullivan R, Kombe D, Blas MM, Parham G, Kassami N, Conteh L.

Lancet. 2017 Feb 25;389(10071):847-860. doi: 10.1016/S0140-6736(16)31392-7. Epub 2016 Nov 1. Review.

43.

KIF1A mediates axonal transport of BACE1 and identification of independently moving cargoes in living SCG neurons.

Hung CO, Coleman MP.

Traffic. 2016 Nov;17(11):1155-1167. doi: 10.1111/tra.12428. Epub 2016 Oct 5.

44.

Adjusting for overdispersion in piecewise exponential regression models to estimate excess mortality rate in population-based research.

Luque-Fernandez MA, Belot A, Quaresma M, Maringe C, Coleman MP, Rachet B.

BMC Med Res Methodol. 2016 Oct 1;16(1):129.

45.

Do cancer survival statistics for every hospital make sense?

Morris M, Quaresma M, Pitkäniemi J, Morris E, Rachet B, Coleman MP.

Lancet Oncol. 2016 Sep;17(9):1192-4. doi: 10.1016/S1470-2045(16)30391-6. Epub 2016 Aug 30. No abstract available.

46.

Synaptophysin depletion and intraneuronal Aβ in organotypic hippocampal slice cultures from huAPP transgenic mice.

Harwell CS, Coleman MP.

Mol Neurodegener. 2016 Jun 10;11(1):44. doi: 10.1186/s13024-016-0110-7.

47.

Application of virtual screening to the discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with potential for the treatment of cancer and axonopathies.

Clark DE, Waszkowycz B, Wong M, Lockey PM, Adalbert R, Gilley J, Clark J, Coleman MP.

Bioorg Med Chem Lett. 2016 Jun 15;26(12):2920-2926. doi: 10.1016/j.bmcl.2016.04.039. Epub 2016 Apr 16.

48.

Traumatic Axonal Injury: Mechanisms and Translational Opportunities.

Hill CS, Coleman MP, Menon DK.

Trends Neurosci. 2016 May;39(5):311-324. doi: 10.1016/j.tins.2016.03.002. Epub 2016 Mar 31. Review.

49.

Mislocalization of neuronal tau in the absence of tangle pathology in phosphomutant tau knockin mice.

Gilley J, Ando K, Seereeram A, Rodríguez-Martín T, Pooler AM, Sturdee L, Anderton BH, Brion JP, Hanger DP, Coleman MP.

Neurobiol Aging. 2016 Mar;39:1-18. doi: 10.1016/j.neurobiolaging.2015.11.028. Epub 2015 Dec 7.

50.

Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011: a population-based study.

Abrahão R, Keogh RH, Lichtensztajn DY, Marcos-Gragera R, Medeiros BC, Coleman MP, Ribeiro RC, Keegan TH.

Br J Haematol. 2016 Apr;173(2):292-302. doi: 10.1111/bjh.13944. Epub 2016 Feb 5.

Supplemental Content

Loading ...
Support Center